biotech

Welcome to the 'biotech' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'biotech'.

Are you an expert about 'biotech'? Do you want to be the Technorati authority on 'biotech'? You can write a description that will appear right here: Join Blogcritics!

Original Technorati articles tagged “biotech”

• in Business
  Colorado Startup VetDC Targets Biotech Breakthroughs for Pets
  Colorado State University Spinoff Signs Licensing Deal for Cancer Drug
  by johnjegan / on Mar 16, 2011
• in Business
  Pharmaceutical Stocks Expected to Skyrocket in 2011
  2011 pharmaceutical stocks to take a look at.
  by caroline1234 / on Jan 25, 2011
• in Family
  FDA Logic Provides Another Reason To Choose Wild-Caught Salmon
  The FDA is on the verge of approving genetically modified salmon, but wont require GM labeling AND will not allow non-modified salmon to be labeled as such
  by terrasanoblog / on Sep 21, 2010

Latest blogosphere posts tagged “biotech”

 

• Biotage Releases New Catalog and Technical Guide for Sample Preparation and Evaporation

  
  Your Story — Authority: 489
  Biotage® introduced their 2012 catalog of analytical sample preparation products for chemistry professionals. Uppsala, Sweden, January 28, 2012 — Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, introduced their 2012 catalog of analytical sample ...
  1 day ago

• 2012 Venture Outlook: Some Bright Spots and Some Gloom

  
  Xconomy — Authority: 639
  Bruce V. Bigelow It’s that outlook time of year, and Mark Heesen, president of the National Venture Capital Association (NVCA), was in San Diego earlier this week, talking about the 2012 outlook for venture capital. Today he’ll make a similar presentation to the New Jersey Technology Council. Next week,  John ...
  2 days ago

• Cancer Institute Sues Biotech Company for More than $1 Billion Charging IP Theft

  
  Patent Baristas — Authority: 89
  A nonprofit cancer research institute has sued biotechnology company Agios and one of its cofounders for more than $1 billion, alleging they took intellectual property developed at the institute and used it to start a for-profit business. The Leonard and Madlyn Abramson Family Cancer Research Institute, part of the ...
  2 days ago

• Biotech Stock Mailbag: Vival, Hep C Drugs

  
  TheStreet.com — Authority: 595
  BOSTON (TheStreet) --Before I get to your emails and tweets, I want to remind everyone to submit your entries to my FDA Drug Approval Contest. Later today, the FDA is expected to announce its approval decision for Amylin Pharmaceuticals diabetes drug Bydureon. This will be followed by 16 more drug approval decisions ...
  2 days ago

• Stocks to Watch: P&G, Ford, Starbucks

  
  TheStreet.com — Authority: 595
  NEW YORK (TheStreet) -- Procter & Gamble, the consumer products giant, reported core profit for the fiscal second quarter of $1.10 a share on sales of $22.14 billion. Analysts expected it to post earnings of $1.08 a share on revenue of $22.19 billion. Net earnings were 57 cents a share. A year ago, P&G; ...
  2 days ago

• OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation

  
  Xconomy — Authority: 639
  Luke Timmerman Prostate cancer was once a backwater for innovation, but suddenly it’s become one of the most competitive battlegrounds in all of biotech. And one of the darkhorses in this race, Bothell, WA and Vancouver, BC-based OncoGenex Pharmaceuticals, is getting ready to show next week whether it has another ...
  2 days ago

• Why Biogen Idec Got Out of the Corporate VC Business

  
  Xconomy — Authority: 639
  Luke Timmerman Steve Holtzman got his first taste of corporate venture capital back in 1987, when he raised money from SR One, back when it was part of an old company known as Smith, Kline & French. The concept was unorthodox 25 years ago, yet over time, most every Big Pharma company has become an active ...
  2 days ago

• Breakthrough in diagnosing genetic mitochondrial disease and others

  
  Innovation Toronto — Authority: 127
  They found about 25 per cent of cases could be diagnosed straight awayA GROUP of scientists says a breakthrough in gene technology offers fresh hope to people suffering from some potentially fatal genetic conditions. The team based at the Murdoch Children’s Research Institute in Melbourne and the Broad Institute in ...
  2 days ago

• Theraclone, VLST Founders Form New Antibody Startup, V-Gene

  
  Xconomy — Authority: 639
  Luke Timmerman Two of the scientific founders of a couple of Seattle’s best-funded biotech startups have come together in a new company that aims to create a valuable antibody drug candidates while burning through the least amount of venture capital possible. The new Seattle-based company, called V-Gene, is ...
  3 days ago

• Affymax Prepares to Mount First Challenge to Amgen Anemia Drug Monopoly

  
  Xconomy — Authority: 639
  Luke Timmerman Affymax shocked the world when an FDA advisory committee recommended last month that its anemia drug was good enough to earn a spot on the U.S. market. Now the Palo Alto, CA-based company (NASDAQ: AFFY ) is making all sorts of moves behind the scenes that will determine how big a bite it will ...
  4 days ago

• Patent Agent - Small Corporation - San Diego, Calif.

  
  Patent Law Jobs by Patently-O — Authority: 114
  Verenium Corporation , a pioneer and recognized leader in the development and commercialization of high-performance enzymes for use in industrial processes, is seeking a Patent Agent. Are you an IP professional seeking a new role in a cutting edge, fast-paced green technology company? Is getting involved in the ...
  4 days ago

• Human stem cell therapy works in blind patients in first trial

  
  Innovation Toronto — Authority: 127
  The breakthrough holds out the hope of a cure in the future for age-related macular degeneration Scientists have improved the sight of two people who were almost blind by injecting their eyes with stem cells from embryos. The two women, both registered as blind, saw their vision improve in a matter of weeks after ...
  4 days ago

• Online Gamers Achieve First Crowd-Sourced Redesign of Protein

  
  Innovation Toronto — Authority: 127
  “Using the Foldit players allows the researchers to use human intuition at a scale that is unprecedented.” Next up will be a more useful target–potent versions of small protein inhibitors that bind to and block the 1918 pandemic influenza virus Obsessive gamers’ hours at the computer have now topped ...
  5 days ago

• Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race

  
  Xconomy — Authority: 639
  Luke Timmerman Vertex Pharmaceuticals went from king of the hill in the treatment of hepatitis C to yesterday’s news in about six wild months. But while many on Wall Street say Vertex’s big drug will soon become obsolete, Vertex and its small partner in South San Francisco have quietly put themselves in ...
  5 days ago

• Vaccines to Boost Immunity Where It Counts, Not Just Near Shot Site

  
  Innovation Toronto — Authority: 127
  A new avenue of personalized medical treatment — personalized vaccines Researchers at Duke University Medical Center have created synthetic nanoparticles that target lymph nodes and greatly boost vaccine responses, said lead author Ashley St. John, PhD, a researcher at Duke-NUS Graduate Medical School. The paper was ...
  5 days ago

• Cellceutix Featured on Front Page of Boston Business Journal

  
  OTC Showcase - Small Cap Stock Research — Authority: 120
  Cellceutix Corporation (OTCBB: CTIX) (“the Company”), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat unmet medical conditions, is pleased to announce that it was featured Friday, January 20th on the front page of the Boston Business Journal print edition. Owned by ...
  6 days ago

• Edible Microchips, Biometric Identity Systems And Mind Reading Computers

  
  Jesus Lives! — Authority: 134
  From Right Side News.Com As technology continues to advance at an exponential rate, will we someday find ourselves living in a “scientific dictatorship” where virtually everything that we do, say and think is monitored and controlled by technology? To many of you that may sound like a wild assertion, but ...
  1 week ago

• Millennium, Looking to Fend Off Onyx, Eagerly Awaits FDA Word on New Velcade

  
  Xconomy — Authority: 639
  Luke Timmerman The drug that made Millennium into a biotech power is on the verge of getting a subtle but meaningful upgrade, just in time to help the company fend off a serious new competing therapy from South San Francisco-based Onyx Pharmaceuticals (NASDAQ: ONXX ). Cambridge, MA-based Millennium, the cancer ...
  1 week ago

• Researchers engineer E. Coli to produce ethanol directly from brown seaweed with yield equivalent to ~80% of the theoretical maximum

  
  Green Car Congress — Authority: 585
  Design of the microbial platform for production of biofuels and renewable commodity chemical compounds from macroalgae. Wargacki et al. Click to enlarge. A team of scientists from Bio Architecture Lab (BAL) in Berkeley, California, ( earlier post ) has engineered a strain of Eschericia coli to break down and ...
  1 week ago

• Biotech Stock Mailbag: Celldex, Hep C Bubble, Al Mann Anger

  
  TheStreet.com — Authority: 595
  BOSTON (TheStreet) -- Welcome to this weeks Biotech Stock Mailbag. @WilliamPShelley kicks it off with a tweet concerning Celldex Therapeutics. "What do you think about $CLDX. Volume is up in these 2 days and over $4!" Celldex was once forgotten but, apparently, no longer. I highlighted Celldex and its breast-cancer ...
  1 week ago

Comments about biotech